Looking ahead to 2030, our model projects MRNA could trade at an average price of $54.42, with a potential range between $40.82 and $68.03. This represents a potential 18.3% return from today's price.
Jan 12 (Reuters) - Moderna said on Monday ‌it expects to report around $1.9 billion in ‌sales for 2025, putting it near the upper end of its previously projected $1.6 billion to $2 billion forecast ...